US antitrust regulators have approved Microsoft’s deal to buy artificial intelligence and speech technology company Nuance Communications, according to a filing made by Nuance to the government.
Announced in April, the US$16 billion deal came after the companies partnered in 2019 to automate healthcare administrative work, such as documentation.
According to Reuters, Nuance told the US Securities and Exchange Commission on Friday, June 4, that the deadline for the US government to object to the deal had expired on June 1.
That expiration “satisfies one of the conditions to the closing of the merger,” the company said in the filing.
The Nuance deal is expected to bolster Microsoft’s presence in healthcare, with Microsoft CEO Satya Nadella saying, “Nuance provides the AI layer at the healthcare point of delivery and is a pioneer in the real-world application of enterprise AI. AI is technology’s most important priority, and healthcare is its most urgent application. Together, with our partner ecosystem, we will put advanced AI solutions into the hands of professionals everywhere to drive better decision-making and create more meaningful connections, as we accelerate growth of Microsoft Cloud for Healthcare and Nuance.”
When the deal closes, Mark Benjamin will remain CEO of Nuance and he will be reporting to Scott Guthrie, executive vice president of Cloud & AI at Microsoft.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI